Table 3 Number (%) of (non-)significant meta-analyses under different scales for two-stage models (“binary” and “OEV” data)
Outcome | OR | HR (O-E & V) | ||||
|---|---|---|---|---|---|---|
“binary” | ||||||
Significant | Non-significant | Significant | Non-Significant | |||
HR (clog-log) | All-cause mortality | Significant | 106 (15%) | 2 (0.1%) | ||
Non-significant | 4 (0.6%) | 603 (84%) | ||||
“OEV” | ||||||
Significant | Non-significant | Significant | Non-Significant | |||
HR (clog-log) | Overall Survival | Significant | 20 (29%) | 1 (0.2%) | 18 (26%) | 10 (14%) |
Non-significant | 1 (0.2%) | 47 (68%) | 3 (4%) | 38 (55%) | ||
Progression / Disease free Survival | Significant | 9 (29%) | 0 (0%) | 8 (26%) | 6 (19%) | |
Non-significant | 1 (3%) | 21 (68%) | 1 (3%) | 16 (52%) | ||
HR (O-E &V) | Overall Survival | Significant | 18 (26%) | 10 (14%) | ||
Non-significant | 3 (4%) | 38 (55%) | ||||
Progression / Disease free Survival | Significant | 9 (29%) | 5 (16%) | |||
Non-significant | 1 (3%) | 16 (52%) | ||||